We developed five major blood-based cancer tests for the early detection and surveillance of cancer recurrence in breast cancer, colorectal cancer, lung cancer, prostate, and ovarian cancer.
After initial cancer treatment, the disease may return and regrow UNCHECKED within the patient. This can lead to metastasis, where the tumor takes hold in different areas of the body and can have damaging effects on the function of vital organs, ultimately leading to patient death.
MammoCheck is a serum-based test developed to detect early-stage breast cancer recurrence years ahead of time.
IgoCheck is a serum-based test developed to detect early-stage colorectal cancer recurrence.